Erythromycin resistance features and biofilm formation affected by subinhibitory erythromycin in clinical isolates of Staphylococcus epidermidis

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 1, 2016, Pages 33-40

  He, Hong Jing ^a   Sun, Feng Jun ^a   Wang, Qian ^a   Liu, Yao ^a   Xiong, Li Rong ^a   Xia, Pei Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biofilm formation; Erythromycin; Resistance feature; Staphylococcus epidermidis; Subminimal inhibitory concentration

Indexed keywords

ERYTHROMYCIN; ANTIINFECTIVE AGENT; TRANSFER RNA METHYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DRUG SENSITIVITY; ERMA GENE; ERMB GENE; ERMC GENE; GENE EXPRESSION; GENOTYPE; HUMAN; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; STAPHYLOCOCCUS EPIDERMIDIS; VIRUS CULTURE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENE EXPRESSION PROFILING; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TRNA METHYLTRANSFERASES;

EID: 84958041305     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.03.001     Document Type: Article

References (37)

1. Kolak R.R. Antibiotics in the critically ill. Med Pregl 2010, 63:27-32.
2. Lipman J., Boots R. A new paradigm for treating infections: "go hard and go home". Crit Care Resusc 2009, 11:276-281.
3. Odenholt I. Pharmacodynamic effects of subinhibitory antibiotic concentrations. Int J Antimicrob Agents 2001, 17:1-8.
4. Schadow K.H., Simpson W.A., Christensen G.D. Characteristics of adherence to plastic tissue culture plates of coagulase-negative staphylococci exposed to subinhibitory concentrations of antimicrobial agents. J Infect Dis 1988, 157:71-77.
5. Hoffman L.R., D'Argenio D.A., MacCoss M.J., Zhang Z., Jones R.A., Miller S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005, 436:1171-1175.
6. Wagner T., Soong G., Sokol S., Saiman L., Prince A. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Chest 2005, 128:912-919.
7. Wozniak D.J., Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004, 125:62-69.
8. Presterl E., Hajdu S., Lassnigg A.M., Hirschl A.M., Holinka J., Graninger W. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2009, 53:3205-3210.
9. Santos A.P., Watanabe E., Andrade D.D. Biofilm on artificial pacemaker: fiction or reality?. Arq Bras Cardiol 2011, 97:e113-e120.
10. Shanks R.M., Sargent J.L., Martinez R.M., Graber M.L., O'Toole G.A. Catheter lock solutions influence staphylococcus biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006, 21:2247-2255.
11. López M.R., de León L., Moujir L. Antibacterial properties of phenolic triterpenoids against. Staphylococcus epidermidis. Planta Med 2011, 77:726-729.
12. Lönn-Stensrud J., Naemi A.O., Benneche T., Petersen F.C., Scheie A.A. Thiophenones inhibit Staphylococcus epidermidis biofilm formation at nontoxic concentrations. FEMS Immunol Med Microbiol 2012, 65:326-334.
13. Gomes F., Teixeira P., Cerca N., Azeredo J., Oliveira R. Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix. Curr Microbiol 2011, 63:354-359.
14. Hofmann C.M., Bednar K.J., Anderson J.M., Marchant R.E. Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide. J Biomed Mater Res A 2012, 100:1061-1067.
15. Wang Q., Sun F.J., Liu Y., Xiong L.R., Xie L.L., Xia P.Y. Enhancement of biofilm formation by subinhibitory concentrations of macrolides in ICAADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 2010, 54:2707-2711.
16. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20 2010, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA, USA.
17. O'Toole G., Kaplan H.B., Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000, 54:49-79.
18. Watanakunakorn C. In-vitro induction of resistance in coagulase-negative Staphylococci to vancomycin and teicoplanin. J Antimicrob Chemother 1988, 22:321-324.
19. Haas C.E., Nix D.E., Schentag J.J. In vitro selection of resistant Helicobacter pylori. Antimicrob Agents Chemother 1990, 34:1637-1641.
20. Kalenić S., Plecko V., Kresić S., Presecki V., Tripković V., Zele-Stracević L., et al. Helicobacter pylori: in vitro induction of resistance to azithromycin. Chemotherapy 1998, 44:17-20.
21. Oliveira M., Santos V., Fernands A., Bernardo F., Vilela C.L. Antimicrobial resistance and in vitro biofilm-formation ability of enterococci from intensive and extensive farming broilers. Poultry Science Association Inc 2010, 89:1065-1069.
22. Elisotetta N., Giulia F., Roberta M., Melissa S., Mario C., Laura P., et al. Differences in biofilm formation and aggregative adherence between β-lactam susceptible and β-lactamases producing P. mirabilis clinical isolates. New Microbiologica 2010, 33:37-45.
23. Dunne W.M. Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci. Antimicrob Agents Chemother 1990, 34:390-393.
24. Boehm A., Steiner S., Zaehringer F., Casanova A., Hamburger F., Ritz D., et al. Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol Microbiol 2009, 72:1500-1516.
25. Kaplan J.B. Antibiotic-induced biofilm formation. Int J Arif Organs 2011, 34:737-751.
26. Elliott D., Burns J.L., Hoffman L.R. Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2010, 4:3024-3026.
27. Leclercq R., Courvalin P. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991, 35:1267-1272.
28. Abbassi M.S., Bouchami O., Touati A., Achour W., Ben Hassen A. Clonality and occurrence of genes encoding antibiotic resistance and biofilm in methicillin-resistant Staphylococcus epidermidis strains isolated from catheters and bacteremia in neutropenic patients. Curr Microbiol 2008, 57:442-448.
29. Bouchami O., Achour W., Ben Hassen A. Prevalence and mechanisms of macrolide resistance among Staphylococcus epidermidis isolates from neutropenic patients in Tunisia. Clin Microbiol Infect 2007, 13:103-106.
30. Gherardi G., De Florio L., Lorino G., Fico L., Dicuonzo G. Macrolide resistance genotypes and phenotypes among erythromycin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci, Italy. FEMS Immunol Med Microbiol 2009, 55:62-67.
31. Campoccia D., Montanaro L., Pirini V., Ravaioli S., Arciola C.R. Prevalence of genes for aminoglycoside-modifying enzymes in Staphylococcus epidermidis isolates from orthopedic postsurgical and implant-related infections. J Biomed Mater Res A. 2009, 88:654-663.
32. Gatermann S.G., Koschinski T., Friedrich S. Distribution and expression of macrolide resistance genes in coagulase-negative staphylococci. Clin Microbiol Infect. 2007, 13:777-781.
33. Darby C., Hsu J.W., Ghori N., Falkow S. Caenorhabditis elegans: plague bacteria biofilm blocks food intake. Nature 2002, 417:243-244.
34. Kaplan J.B., Velliyagounder K., Ragunath C., Rohde H., Mack D., Knobloch J.K., et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilm. J Bacteriol 2004, 186:8213-8220.
35. Knobloch J.K., Bartscht K., Sabottke A., Rohde H., Feucht H.H., Mack D. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J Bacteriol 2001, 183:2624-2633.
36. Torma M.A., Martí M., Valle J., Manna A.C., Cheung A.L., Lasa I., et al. SarA Is an essential positive regulator of Staphylococcus epidermidis biofilm development. J Bacteriol 2005, 187:2348-2356.
37. Xu L., Li H., Vuong C., Vadyvaloo V., Wang J., Yao Y., et al. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect Immun 2006, 74:488-496.